Veralox Therapeutics

Frederick, MD · Founded 2017 · Privately Held (backing)

Developer of small molecule therapeutics designed to target heparin-induced thrombocytopenia and thrombosis. Veralox Therapeutics is based in Frederick, MD and was founded in 2017. It was valued at $66 million at its later-stage round in Jun 2023, the last priced event on record. It has raised $41.2 million across 3 recorded rounds; the latest was a $24 million early-stage round in Jun 2023.

PMV mark · valuation
$66.0M
Oct 2026
Priced at
its later-stage round
Jun 2023
Total raised
$41.2M
Last round
Early Stage VC
Jun 2023

Who backs Veralox Therapeutics?

15 investors
InvestorType
Alumni VenturesVenture capital
Alexandria Venture InvestmentsOther
TEDCOVenture capital
NYBC VenturesVenture capital
Point Field PartnersFamily office
Genesys Capital—
Jefferson Accelerator Zone—
Pappas Capital—
Sanofi Ventures—
T1D Fund—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Veralox Therapeutics investors

15 investors are on record for Veralox Therapeutics, including Alumni Ventures, Alexandria Venture Investments, TEDCO and NYBC Ventures. The early-stage round in Jun 2023 drew 14 investors.

Free account
More of Veralox Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Veralox Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View